Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Effective and safe injection for treating spontaneous pneumothorax

An injection, spontaneous technology, applied in non-active ingredients medical preparations, medical preparations containing active ingredients, nitrile/isonitrile active ingredients, etc., can solve problems such as air leakage, improve anti-aging, tissue The effect of small reaction and strong adhesion

Inactive Publication Date: 2020-10-30
AFFILIATED HOSPITAL OF ZUNYI MEDICAL COLLEGE
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Even in today's mature technology of clinical thoracoscopic or videoscopic surgery, there will still be air leakage after surgery

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] An effective and safe injection for treating spontaneous pneumothorax, an effective and safe injection for treating spontaneous pneumothorax, the injection for treating spontaneous pneumothorax comprises α-n-butyl cyanoacrylate, nanometer dioxide Silicon and 50% dextrose solution.

[0025] The method for using the injection for the treatment of spontaneous pneumothorax comprises the following steps:

[0026] S1, proportioning the mixed solution of α-n-butyl cyanoacrylate 5g, hydrophobic nano silicon dioxide 5g and 50% glucose solution 50ml, and make α-n-butyl cyanoacrylate 5g, hydrophobic nano silicon dioxide 5g and 100ml of 50% glucose solution;

[0027] S2. After the mixed solution prepared in S1 is left to stand for 5-10 minutes, slowly inject and drain into the chest cavity.

[0028] The injection is used for injection at lesion sites and guided by special body positions.

Embodiment 2

[0030] An effective and safe injection for treating refractory pneumothorax, said injection for treating refractory pneumothorax comprises n-butyl α-cyanoacrylate, human fibrin adhesive, talcum powder 10g, 50% glucose solution, saline, and lidocaine hydrochloride.

[0031] An effective and safe injection for treating refractory pneumothorax, the method for using the injection for treating refractory pneumothorax comprises the following steps:

[0032] S1, proportioning α-n-butyl cyanoacrylate 5g, human fibrin adhesive 5g, normal saline 100ml, talcum powder 3g and 50% glucose solution 100ml;

[0033] S2. After mixing 3 g of talcum powder and 100 ml of 50% glucose solution with 10 ml of lidocaine hydrochloride, the chest cavity drainage tube is injected and drained;

[0034] S3. Mix 5 g of n-butyl α-cyanoacrylate, 5 g of human fibrin adhesive and 100 ml of normal saline, and then slowly inject and drain into the chest cavity.

[0035] The injection is used for injection at les...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an effective and safe injection for treating spontaneous pneumothorax. The injection for treating spontaneous pneumothorax comprises alpha-n-butyl cyanoacrylate, nano silicon dioxide and a 50% glucose solution. The invention also provides an effective and safe injection for treating refractory pneumothorax. The injection for treating refractory pneumothorax comprises alpha-n-butyl cyanoacrylate, a human fibrin adhesive, 10g of talcum powder, a 50% glucose solution, normal saline and lidocaine hydrochloride. According to the invention, alpha-n-butyl cyanoacrylate is added, so that alpha-n-butyl cyanoacrylate can be used for quickly adhering body tissues at room temperature, and is strong in adhesion force and non-toxic; the reaction to tissues is small, thrombus is not formed, and simple sterilization can be realized; no trace is left after skin incision anastomosis, and the hemostatic function is achieved on a wound; the alpha-n-butyl cyanoacrylate can also be used for adhesion and hemostasis of visceral organs; and the adopted nano silicon dioxide has ultraviolet-resistant optical performance, so that the ageing resistance, strength and chemical resistanceof other materials can be improved.

Description

technical field [0001] The invention relates to the technical field of pneumothorax injection, in particular to an effective and safe injection for treating spontaneous pneumothorax. Background technique [0002] At present, pneumothorax is an emergency in thoracic surgery, usually due to lung disease or external force, the lung tissue and visceral pleura rupture, or the tiny emphysema bubbles near the lung surface rupture, and the air in the lung and bronchus escapes into the pleural cavity. Divided into traumatic pneumothorax and spontaneous pneumothorax. Those caused by trauma to the chest wall or lungs are called traumatic pneumothorax; those caused by spontaneous rupture of lung tissue due to disease are called "spontaneous pneumothorax". [0003] At present, spontaneous pneumothorax has been found. After 2 weeks of closed chest drainage and negative pressure absorption, there is still air leakage. Such phenomena are regarded as refractory spontaneous pneumothorax. Ev...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/08A61K47/26A61K33/00A61K31/275A61P11/00A61P7/04
CPCA61K9/08A61K9/0019A61K47/26A61K33/00A61K31/275A61P11/00A61P7/04A61K2300/00
Inventor 王艳赵旭王峰
Owner AFFILIATED HOSPITAL OF ZUNYI MEDICAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com